deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT00778479

Evaluation of the Safety of Sepraspray in Open Abdominal Surgery

Sponsor: Genzyme, a Sanofi Company

Interventions Sepraspray
Updated 7 times since 2017 Last updated: Mar 19, 2015 Started: Oct 31, 2008 Primary completion: May 31, 2009 Completion: May 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Terminated by Sponsor: see details below

This NA trial investigates Adhesion Prevention (Abdominal) and is currently terminated or withdrawn. Genzyme, a Sanofi Company leads this study, which shows 7 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 11 months · monthly snapshotTerminated

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated NA

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated NA

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated NA

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

Show 2 earlier versions
  1. Feb 2017 — Jun 2018 [monthly]

    Terminated NA

  2. Jan 2017 — Feb 2017 [monthly]

    Terminated NA

    First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Genzyme, a Sanofi Company
Data source: Sanofi

For direct contact, visit the study record on ClinicalTrials.gov .